Protozoan Plasmodium parasites are the causative agents of malaria, a deadly disease that
continues to afflict hundreds of millions of people every year. Infections with malaria …

Emerging antimalarial drug resistance may undermine current efforts to control and
eliminate Plasmodium vivax, the most geographically widespread yet neglected human …

Challenges in classifying recurrent Plasmodium vivax infections constrain surveillance of
antimalarial efficacy and transmission. Recurrent infections may arise from activation of …

Relapses arising from dormant liver-stage Plasmodium vivax parasites (hypnozoites) are a
major cause of vivax malaria. However, in endemic areas, a recurrent blood-stage infection …

Abstract “The Primate Malarias” book has been a uniquely important resource for multiple
generations of scientists, since its debut in 1971, and remains pertinent to the present day …

Mainstay treatment for Plasmodium vivax malaria has long relied on chloroquine (CQ)
against blood-stage parasites plus primaquine against dormant liver-stage forms …

Background Plasmodium vivax resistance to chloroquine (CQ) has been reported
worldwide, although the World Health Organization clinical drug efficacy studies protocol …

Plasmodium vivax infections often consist of heterogenous populations of parasites at
different developmental stages and with distinct transcriptional profiles, which complicates …

The interaction between Plasmodium vivax Duffy binding protein (PvDBP) and Duffy antigen
receptor for chemokines (DARC) has been described as critical for the invasion of human …

Plasmodium vivax has become the predominant malaria parasite and a major challenge for
malaria elimination in the Greater Mekong Subregion (GMS). Yet, our knowledge about the …